Citius Oncology Statistics
NASDAQ: CTORHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.8598+0.0038 (+0.44%)
Market open · Delayed 15 min · as of Oct 8, 10:01 AM ET
Citius Oncology by the numbers
Citius Oncology has a market capitalization of $90.9 million based on 105.76M shares outstanding. With trailing EPS of $-0.48, Citius Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.7% above its 50-day average and 1.5% below its 200-day average.
Average daily trading volume is 99.72K shares, or about $85,739 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CTOR valuation vs. peer median
| Metric | CTOR | Peer median | Difference |
|---|---|---|---|
| Market cap | $90.93M | $89.36M | +2% |
| Avg. volume | 99.72K | 255.95K | -61% |
Peer median across 8 companies: MIST, RLYB, OKUR, EQ, BMEA, PMN, TELO, ANIX.
Valuation
- Market cap
- $90.93M
- EPS (TTM)
- $-0.48
- Shares outstanding
- 105.76M
Price and trading
- Previous close
- 0.856
- Open
- 0.87
- Day range
- 0.85 – 0.87
- 52-week range
- 0.491 – 2.25
- 52-week change
- -54.73%
- 50-day moving average
- 0.8457
- 200-day moving average
- 0.8726
- Beta
- —
- Volume
- 17.59K
- Average volume
- 99.72K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 90.93M
- Eps
- -0.48
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.25
- Week52 Low
- 0.49
- Avg Volume
- 99,720.00
- Shares Outstanding
- 105.76M
- Ma50
- 0.85
- Ma200
- 0.87
- Pct From52w High
- -61.79%
- Pct From52w Low
- 75.11%